BD innovation highlights new flow cytometry tech

By Monish Makena, The Science Advisory Board contributing writer

January 24, 2022 -- A new study conducted by Becton Dickinson (BD) in collaboration with the European Molecular Biology Laboratory (EMBL), which was published as the cover story of Science on January 20, profiles a BD innovation in flow cytometry that adds fluorescence imaging and image-based decisioning to sort individual cells at an exceptionally high speed.

The technology is based on the visual details of each cell and not solely on the type or quantity of biomarkers that are present and has the potential to transform immunology, cell biology, and genomics research to enable new cell-based therapeutic discovery.

The new innovation from BD, known as BD CellView Image Technology, can capture multiple images of individual cells flowing through the system at a speed of 15,000 cells per second. It adds a previously impossible capability of sorting cells based on detailed microscopic image analysis of individual cells at this speed.

By imaging the distribution of biomarkers with this technology, researchers can obtain detailed information about cells that was previously invisible in traditional flow cytometry experiments. This enables scientists to answer complex biological questions, such as how cells grow, function, and interact. It also allows researchers to study exact locations of viruses or proteins within a cell -- all at a highly accelerated pace.

Image-enabled cell sorting identifies and isolates cells of interest out of a complex pool of cells at speeds of up to 15,000 cells per second.
Image-enabled cell sorting identifies and isolates cells of interest out of a complex pool of cells at speeds of up to 15,000 cells per second. Image courtesy of Tobias Wuestefeld/BlueClay Studios.

In the study, researchers used BD CellView Image Technology to study regulators of the nuclear factor kappa light chain enhancer of activated B cells (NF-κB) pathway. NF-κB is a protein complex that plays an important role in cellular immunity and stress response. The EMBL team measured the activity in this pathway by tracking the location of RelA, an REL-associated protein involved in NF-κB heterodimer formation, nuclear translocation, and activation that moves from the cytoplasm into the nucleus of the cell upon activation.

Using BD CellView Image Technology, the screen allowed the scientists to identify several novel regulators of this important cellular pathway in a matter of hours, instead of days, as would be required using conventional approaches. These results have broad implications for accelerating the pace of genomic research and therapeutic discovery, according to the team.

BD introduces robotics to automate microbial identification
BD has received clearance from the U.S. Food and Drug Administration for the BD Kiestra Identifa system, which is designed to automate the preparation...
BD launches new benchtop cell analyzer
Medical technology company Becton Dickinson (BD) has launched a new benchtop cell analyzer called FACSymphony A1 that offers new capabilities in flow...
BD launches new digital marketplace for flow cytometry
Becton Dickinson (BD) has launched, an updated digital marketplace for flow cytometry. The new website provides an enhanced online purchasing...
BD posts healthy global, U.S. Q4 revenues
Becton Dickinson (BD) has reported worldwide fourth quarter revenues of $4.8 billion, up 4.4% compared to the same period in 2019. U.S. revenues...

Copyright © 2022

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter